Nakamura S, Goshima Y, Yue J L, Miyamae T, Misu Y
Department of Pharmacology, Yokohama City University School of Medicine, Japan.
Jpn J Pharmacol. 1993 May;62(1):107-10. doi: 10.1254/jjp.62.107.
The relevance of endogenously released DOPA to the (+/-)-nicotine-induced increase in locomotor activities was explored in rats. This increase was dose (0.1-1.0 mg/kg, s.c.)-dependent, stereo-selective and mecamylamine (1.0 mg/kg, s.c.)-sensitive, but was not antagonized by L-dopa methyl ester (200 micrograms, i.v.t.), a competitive L-dopa antagonist. Then, by microdialysis, low doses of alpha-methyl-p-tyrosine (alpha-MPT, i.p.) at 1-10 mg/kg, were tested to find a dose that selectively inhibits the basal DOPA release in the striata: the release was consistently inhibited by 3 mg/kg without any tendency to inhibit the basal dopamine release. Pretreatment with this dose did inhibit the nicotine-induced increases in locomotor activities. This suggests that endogeneously released DOPA is in part relevant to the nicotine-induced behavior in rats.